Tatyana Manzik, PA

Tatyana Manzik practices at General Physician in Tonawanda, New York.

Tatyana Manzik's NPI, 1902159643, was assigned on October 18, 2012. Tatyana Manzik holds New York license 015893.

Tatyana Manzik's primary practice is General Physician, at 1208 Niagara Falls Blvd, Tonawanda, NY 14150 in Erie County. The practice phone is (716) 692-3302.

Tatyana Manzik's primary practice is General Physician in Tonawanda, New York. Tatyana Manzik is also affiliated with Sisters of Charity Hospital. The medical group on file is General Physician. Dmand AI also links Tatyana Manzik to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tatyana Manzik practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Tatyana Manzik's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Tatyana Manzik is licensed in New York.

CMS data shows 74 Medicare services from Tatyana Manzik across 2 procedure codes in 2024, for 56 Medicare patients. Medicare paid $5,055 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Tatyana Manzik in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tatyana Manzik's median patient age at 57, with 61% women.

In 2024, Tatyana Manzik wrote 2,394 Medicare Part D claims for 375 patients. 86% of them were for generic drugs. CMS names the drug for 1,888 of them, across 64 drugs with 11 or more claims each, at $202,149 in total drug cost.

Tatyana Manzik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tatyana Manzik as offering telehealth.

CMS Open Payments shows 40 general payments to Tatyana Manzik from 17 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $151.